O30: REKLAIM: A first in human phase Ib clinical trial of FBX-101 (AAVrh10.GALC) intravenously administered after UCBT for infantile Krabbe disease
oleh: Maria Escolar, Mark Vander Lugt, Raymond Wang, Juan Ruiz, Michele Poe, Paul Szabolcs
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2024-01-01 |
Deskripsi
No description available for this item.